StartUp Health community member 9amHealth, the San Diego, CA-based virtual specialty care platform, closed a $26M Series B led by Define Ventures, with participation from SemperVirens VC, Catalio Capital Management, and NewHealth Ventures. The raise is the latest milestone in a funding arc that began when 9amHealth joined the StartUp Health community in 2022 alongside StartUp Health’s participation in a $16M Series A led by 7wire Ventures – at the time, the company was building the market's first fully integrated virtual diabetes clinic, combining clinical protocols, home-delivered medications, at-home labs, and 24/7 specialist access into a single employer-facing benefit. A $9.5M Series A extension in 2024, led by The Cigna Group Ventures, expanded the platform's reach to employers nationwide and put the company at the center of the exploding conversation around GLP-1 affordability and employer pharmacy costs.

The Series B marks a deliberate expansion beyond cardiometabolic care into the broader universe of high-cost specialty conditions. Co-CEO & Co-founder Frank Westermann, who previously co-founded mySugr – the digital diabetes management app acquired by Roche for $100M – has described the company's model as one built for conditions that are expensive precisely because they're poorly managed, not because the science is intractable. The platform already combines AI-enabled clinical workflows with endocrinologists, obesity medicine specialists, and clinical pharmacists to deliver what the company says has produced more than $50M in projected medical and pharmacy savings across two Fortune 100 employers. 

With the new capital, 9amHealth is extending that same infrastructure into additional specialty-level chronic conditions – autoimmune among them – that collectively account for up to 70% of employer pharmacy spend. Lynne O'Keefe of Define Ventures, who will join the Board of Directors as part of the investment, has called the company's track record of clinical outcomes and cost savings in cardiometabolic care a proof point for the broader platform thesis. For employers facing mounting GLP-1 costs and growing specialty drug spend with few integrated management solutions, 9amHealth is positioning itself as the AI-powered layer that finally closes the loop between clinical complexity and commercial accountability.

Other reported global health innovation funding this week included:

Isomorphic Labs, a London, UK-based AI drug design and development company, raised $2.1B from Thrive Capital, Alphabet, GV, MGX, Temasek, CapitalG, and the UK Sovereign AI Fund. <source>

Forus, a New York, NY-based AI-powered network connecting doctors, pharmacies, payers, and biopharma, raised $160M from Thrive Capital, General Catalyst, Accel, Bain Capital Ventures, Redpoint, BoxGroup, and Pear VC. <source>

Nourish, a New York, NY-based virtual nutrition-focused metabolic provider, raised $100M led by Menlo Ventures, with participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, and others. <source>

UroMems, an Eybens, France-based developer of implantable mechatronics technology for stress urinary incontinence, raised $60M from Ajax Health Fund I. <source>

NVision, an Ulm, Germany-based quantum technology company for healthcare, raised $55M from Abbott, Playground Global, Matterwave/b2ventures, Entrée Capital, and the European Investment Bank. <source>

BlueWind Medical, a Salt Lake City, UT-based developer of implantable tibial neuromodulation devices for urgency urinary incontinence, raised $47.8M from undisclosed investors. <source>

BranchLab, a Boulder, CO-based AI platform for pharmaceutical commercialization, raised $26M from McKesson Ventures, FCA Venture Partners, Sanofi Ventures, and AIX Ventures. <source>

Tokaido Health, a San Francisco, CA-based AI-native medication steerage platform, raised $25M from Norwest, Primary, Next Ventures, Constellation, Scrub Capital, and others. <source>

Butterfly Medical, a Yokneam Illit, Israel-based developer of a non-surgical solution for benign prostatic hyperplasia, raised $21M from the European Innovation Council, Junson Capital, MedVenture, and New Rhein Healthcare Investors. <source>

Henry, a Tokyo, Japan-based developer of cloud-based electronic medical record systems for hospitals, raised ¥3B (~$20M) from Angel Bridge, GLOBIS Capital Partners, Japan Post Bank Asset Management, Coral Capital, JIC VGI, Suzuyo, and Mpathy. <source>

Optura, a Nashville, TN-based enterprise healthcare platform for measuring return on AI investment, raised $17.5M from Salesforce Ventures, Echo Health Ventures, Susa Ventures, Matrix Partners, and HC9 Ventures. <source>

Anomaly Insights, a New York, NY-based AI-powered payer intelligence company, raised $17M from Sound Ventures, Alumni Ventures, Link Ventures, Redesign Health, and RRE Ventures. <source>

Sound Wave Innovation, a Tokyo, Japan-based developer of ultrasound-based therapeutic medical devices, raised ¥2.65B (~$17M) from Fiducia Inc., Sumitomo Heavy Industries, iGlobe Partners, and others. <source>

NinaMED, a Melbourne, Australia-based medical device company developing non-invasive neuromodulation therapy for overactive bladder, raised $13.75M from SPRIM Global Investments and SV Health Investors. <source>

Shyld AI, a Sunnyvale, CA-based developer of AI-powered autonomous disinfection and hospital operations platforms, raised $13.4M from Aulis Capital. <source>

Aumet, a Riyadh, Saudi Arabia-based AI-first procurement operating system for healthcare, raised $12M from Emkan Capital, Qatar Development Bank, SABAH VC, AAIC, Shorooq Partners, and Right Side Capital Management. <source>

Vortex Imaging, a Tel Aviv, Israel-based developer of computational ultrasound systems, raised $12M from 10D Ventures, Entrée Capital, Harel T.E.C Partnership, Connecticut Innovations, and PhiFund Ventures. <source>

Knit Health, a San Francisco, CA-based clinical intelligence AI company spun out of UC Berkeley, raised $11.6M from Uncork Capital, Frist Cressey Ventures, and Moxxie Ventures. <source>

Urologic Health, a Jersey City, NJ- and Or Yehuda, Israel-based developer of non-invasive urodynamic diagnostic devices, raised $11M from an undisclosed strategic investor, Edge Medical Ventures, SHD Partners, and Longevity Venture Partners. <source>

Kin Health, a Los Angeles, CA-based patient health record and medical visit summary app, raised $9M from Maveron, Town Hall Ventures, Flex Capital, Eniac Ventures, The Family Fund, Pear VC, Watershed Ventures, and Foundry Square Capital. <source>

Saile, a New York, NY-based AI-powered healthcare staffing and credentialing platform, raised $2.2M from Matchstick Ventures and Headwater Ventures. <source>

SwishX, a Bengaluru, India-based agentic AI platform for pharmaceutical and medtech operations, raised $2.2M from Blume Ventures, Powerhouse Ventures, Sadev Ventures, and Atrium Ventures. <source>

Envoke, a Leeds, United Kingdom-based developer of virtual simulation and remote training software for medical laboratories, raised £1.6M (~$2.13M) from NPIF – Mercia Equity Finance, Finance Yorkshire's Seedcorn Fund, and Foresight Group. <source>

Chromie Health, a New York, NY-based AI-powered hospital workforce management platform, raised $2M from AIX Ventures. <source>

Regulate, a Munich, Germany-based workplace breathwork and performance platform, raised €1.4M (~$1.64M) from 4impact.vc and an angel syndicate including Hanno Renner, Mike Wax, Marlena Hien, and Felix Haas. <source>

Mongoose AI, a New York, NY-based developer of governed AI agents for health insurance plans, raised an undisclosed amount from Vertical Venture Partners, Overstory Partners, and Connecticut Innovations. <source>

Ampa, a Palo Alto, CA-based developer of a portable transcranial magnetic stimulation platform for depression, raised an undisclosed amount (total funding over $25M) from Morningside Ventures, Trimera Capital, Neta Foundation, Jake Collective, and Tim Ferriss. <source>

EnsoData, a Madison, WI-based provider of AI-powered software solutions for sleep medicine, received growth capital financing of an undisclosed amount from CIBC Innovation Banking. <source>

Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox. Follow us on LinkedIn for daily updates on Health Moonshots.